CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- 4 Other acquisition Director acquired 402 shares (code L)
- 4 Other acquisition Director acquired 4,120 shares (code L)
- 4 Other acquisition Director acquired 822 shares (code L)
- 4 Other acquisition Chairman and CEO acquired 822 shares (code L)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Other acquisition Director acquired 4,350 shares (code L)
- 4 Other acquisition Chairman and CEO acquired 870 shares (code L)
- 4 Other acquisition Director acquired 870 shares (code L)
- 4 Other acquisition Director acquired 414 shares (code L)
- 4 Other acquisition Director acquired 341 shares (code L)
- 4 Other acquisition Director acquired 2,280 shares (code L)
- 4 Other acquisition Director acquired 454 shares (code L)
- 4 Other acquisition Chairman and CEO acquired 454 shares (code L)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Shareholder vote results
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
Page 8 of 52 · 1,039 filings